🔎 Trials Near Me

Home › Leucemia mieloide acuta › Missouri › St. Louis

Studi clinici su Leucemia mieloide acuta a St. Louis, MO

22 studi su Leucemia mieloide acuta cercano partecipanti presso sedi a St. Louis e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.

Testo ufficiale dello studio (inglese)

Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

In reclutamentoFase 2
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Missouri Baptist Medical Center, St Louis
  • e altri 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 ott 2026 · NCT05564390

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

In reclutamentoStudio osservazionaleVolontari sani benvenuti
  • Mercy Infusion Center - Chippewa, St Louis
  • Mercy Hospital South, St Louis
  • Missouri Baptist Medical Center, St Louis
  • e altri 4
Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05334069

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

In reclutamentoFase 1
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • e altri 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06484062

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

In reclutamentoFase 2
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • e altri 2
Età da 18 a 59 · Tutti i sessi · Aggiornato il 28 set 2026 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

In reclutamentoFase 3
  • Washington University in St Louis, St Louis
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06852222

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

In reclutamentoFase 2
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • e altri 2
Età da 18 a 59 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

In reclutamentoFase 2
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • e altri 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

In reclutamentoFase 3
  • Washington University School of Medicine, St Louis
  • Mercy Hospital Saint Louis, St Louis
6 Months – 21 Years · Tutti i sessi · Aggiornato il 17 set 2026 · NCT04293562

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

In reclutamentoFase 1/2
  • Washington University in St. Louis School of Medicine, St Louis
30 Days · Tutti i sessi · Aggiornato il 16 set 2026 · NCT04065399

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

In reclutamentoStudio osservazionale
  • Washington University in St. Louis, St Louis
Età 0 e oltre · Tutti i sessi · Aggiornato il 2 set 2026 · NCT07154823

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

In reclutamentoFase 3
  • US-St Louis MO-WASHU, St Louis
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 set 2026 · NCT07223814

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML

In reclutamentoFase 1
  • Washington University in St Louis, St Louis
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT06533761

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

In reclutamentoFase 1/2
  • Cardinal Glennon Children's Medical Center, St Louis
  • Washington University School of Medicine, St Louis
  • Mercy Hospital Saint Louis, St Louis
Fino a 22 anni · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT04726241

Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML

In reclutamentoFase 1/2
  • Washington University School of Medicine, St Louis
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 ago 2026 · NCT06158828

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

In reclutamentoFase 3
  • Washington University School of Medicine in St. Louis, St Louis
29 Days – 21 Years · Tutti i sessi · Aggiornato il 24 ago 2026 · NCT05183035

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

In reclutamentoFase 1
  • Washington University School of Medicine, St Louis
Età 18 e oltre · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT06001788

Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation

In reclutamentoFase 2
  • Washington University, St Louis
Età 18 e oltre · Tutti i sessi · Aggiornato il 11 ago 2026 · NCT06529731

Motixafortide for MRD Sensitization in AML

In reclutamentoFase 2
  • Washington University School of Medicine, St Louis
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 lug 2026 · NCT07392970

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

In reclutamentoStudio osservazionale
  • Cardinal Glennon Children's Medical Center, St Louis
  • Washington University St. Louis, St Louis
  • Washington University/St. Louis Children's Hospital, St Louis
Tutte le età · Tutti i sessi · Aggiornato il 6 lug 2026 · NCT01351545

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

In reclutamentoFase 1
  • Washington University in St. Louis, St Louis
Età 12 e oltre · Tutti i sessi · Aggiornato il 16 mar 2026 · NCT06994676

Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS

In reclutamentoVolontari sani benvenuti
  • Washington University School of Medicine, St Louis
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 ott 2025 · NCT04986657

Studi su Leucemia mieloide acuta in altre città

Altri studi a St. Louis

Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.